Work

Additional file 2: Table S1. of A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma

Year: 2016

Type: dataset

Abstract: FEV1 at Week 12 (all patients and biomarker subgroups). (XLSX 12Â kb)

Source: Figshare

DOI: 10.6084/m9.figshare.c.3616040_d2

Authors: Harris, Jeffrey, Maciuca, Romeo, Bradley, Mary, Cabanski, Christopher, Scheerens, Heleen, Lim, Jeremy, Cai, Fang, Kishnani, Mona, X. Liao, Samineni, Divya, Zhu, Rui, Cochran, Colette, Weily Soong, Diaz, Joseph, Perin, Patrick, Tsukayama, Miguel, Dimov, Dimo, Agache, Ioana, Kelsen, Steven

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4394493935

Cites:

Cited by:

Related to: 10